FDB Warns Its Stakeholders Who Flout New & Revised Guidelines

Stakeholders in the manufacturing, distribution and registration of medicines are undergoing a two day workshop on the revised guidelines for registration of orthodox medicines in Accra.

The Acting Deputy Chief Executive in charge of Drug Registration and Inspectorate Division of the Food and Drugs Authority, FDA, Seth Seaneke, says the Authority is to ensure that medicinal application and registration by players in the industry conforms to the FDA as well as international standards.

Mr. Seaneke added that the revised guidelines will become effective for manufacturers and regulators to find it easy to trade their products on the local as well as international markets. 

Mr. Seaneke further warned that the authority will not succumb to manufacturers and pharmaceutical companies who flout the new and revised guidelines. 

GBC